[This corrects the article DOI: 10.1371/journal.pone.0160755.].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045202PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0164316PLOS

Publication Analysis

Top Keywords

correction cardiomyocyte-specific
4
cardiomyocyte-specific ablation
4
ablation med1
4
med1 subunit
4
subunit mediator
4
mediator complex
4
complex lethal
4
lethal dilated
4
dilated cardiomyopathy
4
cardiomyopathy mice
4

Similar Publications

Background: Recent advances in single cell sequencing have led to an increased focus on the role of cell-type composition in phenotypic presentation and disease progression. Cell-type composition research in the heart is challenging due to large, frequently multinucleated cardiomyocytes that preclude most single cell approaches from obtaining accurate measurements of cell composition. Our studies reveal that ignoring cell type composition when calculating differentially expressed genes (DEGs) can have significant consequences.

View Article and Find Full Text PDF

Cardiomyocyte LGR6 alleviates ferroptosis in diabetic cardiomyopathy via regulating mitochondrial biogenesis.

Metabolism

October 2024

Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China; Cardiovascular Research Institute, Wuhan University, Wuhan, China; Hubei Key Laboratory of Cardiology, Wuhan, China. Electronic address:

Aims: The majority of people with diabetes are susceptible to cardiac dysfunction and heart failure, and conventional drug therapy cannot correct the progression of diabetic cardiomyopathy. We assessed the potential role and therapeutic value of LGR6 (G protein-coupled receptor containing leucine-rich repeats 6) in diabetic cardiomyopathy.

Methods And Results: Type 2 diabetes models were established using high-fat diet/streptozotocin-induced diabetes in mice.

View Article and Find Full Text PDF

Mutation-induced LZTR1 polymerization provokes cardiac pathology in recessive Noonan syndrome.

Cell Rep

July 2024

Stem Cell Unit, Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany; DZHK (German Center for Cardiovascular Research), Göttingen, Germany; Cluster of Excellence "Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells" (MBExC), University of Göttingen, Göttingen, Germany; Translational Neuroinflammation and Automated Microscopy, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Göttingen, Germany. Electronic address:

Noonan syndrome patients harboring causative variants in LZTR1 are particularly at risk to develop severe and early-onset hypertrophic cardiomyopathy. In this study, we investigate the mechanistic consequences of a homozygous variant LZTR1 by using patient-specific and CRISPR-Cas9-corrected induced pluripotent stem cell (iPSC) cardiomyocytes. Molecular, cellular, and functional phenotyping in combination with in silico prediction identify an LZTR1-specific disease mechanism provoking cardiac hypertrophy.

View Article and Find Full Text PDF

is sufficient but not required for cardiomyocyte cell-cycle activation.

Am J Physiol Heart Circ Physiol

August 2024

Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Factors responsible for cardiomyocyte proliferation could serve as potential therapeutics to stimulate endogenous myocardial regeneration following insult, such as ischemic injury. A previously published forward genetics approach on cardiomyocyte cell cycle and ploidy led us to the transcription factor, . Here, we examine the effect of on cardiomyocyte cell cycle during postnatal development and cardiac regeneration using cardiomyocyte-specific gain- and loss-of-function mouse models.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!